141 related articles for article (PubMed ID: 8141715)
1. Issues raised by GUSTO.
White H
Aust N Z J Med; 1993 Dec; 23(6):739-41. PubMed ID: 8141715
[TBL] [Abstract][Full Text] [Related]
2. Mortality results in GUSTO.
Van de Werf F
Aust N Z J Med; 1993 Dec; 23(6):732-4; discussion 735-6. PubMed ID: 8141713
[TBL] [Abstract][Full Text] [Related]
3. The GUSTO trial: background and baseline characteristics.
Aylward P
Aust N Z J Med; 1993 Dec; 23(6):728-31; discussion 735-6. PubMed ID: 8141712
[TBL] [Abstract][Full Text] [Related]
4. Strokes and net clinical benefit.
White H
Aust N Z J Med; 1993 Dec; 23(6):737-8. PubMed ID: 8141714
[TBL] [Abstract][Full Text] [Related]
5. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
[TBL] [Abstract][Full Text] [Related]
6. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
[TBL] [Abstract][Full Text] [Related]
8. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
GUSTO Angiographic Investigators
N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.
Smith BJ
J Accid Emerg Med; 1999 Nov; 16(6):407-11. PubMed ID: 10572811
[TBL] [Abstract][Full Text] [Related]
11. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ
JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Metz BK; White HD; Granger CB; Simes RJ; Armstrong PW; Hirsh J; Fuster V; MacAulay CM; Califf RM; Topol EJ
J Am Coll Cardiol; 1998 Jun; 31(7):1493-8. PubMed ID: 9626825
[TBL] [Abstract][Full Text] [Related]
13. One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators.
Califf RM; White HD; Van de Werf F; Sadowski Z; Armstrong PW; Vahanian A; Simoons ML; Simes RJ; Lee KL; Topol EJ
Circulation; 1996 Sep; 94(6):1233-8. PubMed ID: 8822974
[TBL] [Abstract][Full Text] [Related]
14. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
Bassand JP
Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
[No Abstract] [Full Text] [Related]
15. Lessons we have learned from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries.
Holmes DR; Califf RM; Topol EJ
J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):10S-17S. PubMed ID: 7775708
[TBL] [Abstract][Full Text] [Related]
16. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Reiner JS; Lundergan CF; van den Brand M; Boland J; Thompson MA; Machecourt J; Py A; Pilcher GS; Fink CA; Burton JR
J Am Coll Cardiol; 1994 Nov; 24(6):1439-44. PubMed ID: 7930273
[TBL] [Abstract][Full Text] [Related]
17. The GUSTO trial: is the open-artery hypothesis proven?
Stringer KA; Lindenfeld J
Ann Pharmacother; 1994 Jan; 28(1):97-8. PubMed ID: 8123971
[No Abstract] [Full Text] [Related]
18. Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.
Califf RM; Woodlief LH; Harrell FE; Lee KL; White HD; Guerci A; Barbash GI; Simes RJ; Weaver WD; Simoons ML; Topol EJ
Am Heart J; 1997 Jun; 133(6):630-9. PubMed ID: 9200390
[TBL] [Abstract][Full Text] [Related]
19. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
Lancet; 1990 Jul; 336(8707):71-5. PubMed ID: 1975322
[TBL] [Abstract][Full Text] [Related]
20. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
Singh N; Mironov D; Armstrong PW; Ross AM; Langer A
Circulation; 1996 Apr; 93(7):1388-95. PubMed ID: 8641028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
